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A facile synthesis of ochratoxin A
Abstract
Ochratoxin A (1) was isolated by Steyn and co-workers1 from some strains of Aspergillus ochraceus. Interest
in this toxic metabolite and related compounds such as ochratoxin B (2) is prompted by the health hazard
they pose because of their occurrence in agricultural products.
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of 2a, 14, and 13, in a ratio of 3560:5 as determined by NMR. 
Attempts to convert more of mesylate 2a into product by use of 
additional dimethylcuprate under similar conditions afforded less 
14 and more of the dimethyl ketone 13. 
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Ochratoxin A (1) was isolated by Steyn and co-workers1 
from some strains of Aspergillus ochraceus. Interest in 
this toxic metabolite and related compounds such as 
ochratoxin B (2) is prompted by the health hazard they 
pose because of their occurrence in agricultural products. 
W C H 3  
1, x =  c1 
2 , X = H  
In addition, the availability of more highly oxygenated 
analogues for structure-activity studies is currently limited. 
Although two syntheses of 1 have been previously re- 
ported,2 both are lengthy routes which proceed in low 
overall yield. In conjunction with another project, diester 
3 was prepared in one step from dimethyl 3-oxopentane- 
CH302CCH&OCH2CO,CH3 + CH3COCHCHONa 
OH 
3 
dicarboxylate and the sodium salt of (hydroxy- 
methy1ene)a~etone.~ The transformation of 3 into the 
known acid 5 which has been converted into ochratoxin 
A in one step is the subject of this note. The reaction 
sequence is shown in Scheme I. 
(1) Van der Merwe, K. J.; Steyn, P. S.; Fourie, L. J. Chem. SOC. C. 
(2) Steyn, P. S.; Holzapfel, C. W. Tetrahedron 1967,23,4449. Roberts, 
(3) Prelog, V.; Metzler, 0.; Jesen, 0. Helo. Chin.  Acta 1947, 30,675. 
1965, 7083. 
J. C.; Woollven, P. J. Chem. SOC. C. 1970, 278. 
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Diester 3 was deprotonated with 2 equiv of lithium di- 
isopropylamide in tetrahydrofuran (THFkhexamethyl- 
phosphorictriamide at -78 "C. After the addition of freshly 
distilled acetaldehyde and aqueous acid workup, lactone 
4 could be isolated in 69% yield. Chlorination of 4 with 
sulfuryl chloride in methylene chloride4 afforded a chloro 
lactone which was immediately suspended in methanol and 
saponified with lithium hydroxide. The melting point of 
the resulting acid 5 was in close agreement with the lit- 
erature2 melting point. Since the overall yield from com- 
mercially available starting material is 20%, this route is 
by far the most efficient preparation of ochratoxin inter- 
mediates and should be amenable to considerable varia- 
tion. 
Experimental Section 
General. THF was distilled from lithium aluminum hydride. 
Melting points were determined on a Fisher-Johns melting-point 
apparatus and are uncorrected. Nuclear magnetic resonance 
spectra were determined on Hitachi Perkin-Elmer R20 B. The 
13C NMR spectrum was determined on a JEOLCO FX-9OQ. 
Methyl 3,4-Dihydr0-8-hydroxy-3-methyl-lH-2-benzo- 
pyran-1-one-7-carboxylate (4). To a solution of 14.9 mmol of 
lithium diisopropylamide prepared from 2.4 M n-butyllithium 
(6.2 mL, 14.9 mmol) and diisopropylamine (2.24 mL, 16 mmol) 
in 10 mL of THF at -78 "C was added diester 3 (1.54 g, 6.9 "01) 
in 3 mL of THF over 3 min. After the deep red solution was 
stirred for 10 min, neat acetaldehyde (1.2 mL, 21.5 mmol) was 
added and the solution was stirred for 5 min a t  -78 "C and 15 
min at  0 "C. The reaction was quenched at 0 "C with acetic acid 
(1.99 g) and diluted with ether and water. The aqueous layer was 
extracted twice with ether. The combined organic layers were 
dried over sodium sulfate, concentrated in vacuo, and chroma- 
tographed on silica gel to afford 1.13 g of yellow solid. The solid 
had a melting point of 108-110 "C; NMR (CDC13) 6 1.53 (d, 3 H, 
J = 6 Hz), 2.6-3.2 (m, 2 H), 3.93 (5, 3 H), 4.4-4.8 (m, 1 H), 6.72 
(d, 1 H, J = 9 Hz), 8.03 (d, 1 H, J = 9 Hz). 
5-C hloro-3,4-dihydro-8- hydroxy-3-methyl- 1 H-l-benzo- 
pyran-1-one-7-carboxylic Acid (5). To a solution of 4 (0.361 
g, 1.53 mmol) in 3 mL of methylene chloride at  ambient tem- 
perature was added sulfuryl chloride (0.50 mL, 5.18 mmol). The 
solution was stirred under a nitrogen atmosphere for 20 h, con- 
centrated in vacuo, and suspended in 5 mL of methanol. Lithium 
hydroxide monohydrate (0.700 g, 16.6 mmol) was added to the 
suspension and the suspension was heated to reflux under a 
nitrogen atmosphere for 20 h. After the solution had cooled, most 
of the methanol was removed in vacuo. The semisolid was dis- 
solved in water and extracted once with ether and the aqueous 
layer was then acidified to pH 2 with 3 N HC1. The solution was 
extracted twice over sodium sulfate, concentrated in vacuo, and 
recrystallized from acetonemethanol to afford 0.189 g of a white 
solid with a melting point of 246 OC: NMR (Me,SO-d& 6 1.5 (d, 
3 H, J = 6 Hz), 2.6-3.2 (m, 2 H), 4.3-4.8 (m, 1 H), 8.0 (s, 1 H); 
(4) Efforts to selectively chlorinate 1,4-dihydro-B-hydroxy-3-methyl- 
1H-Z-benzopyran-l-one were initiated in an earlier approach to 1 by John 
Pezzanite. 
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I3C NMR (Me2SO-d6) 20.00, 32.08, 74.23, 112.31, 117.73, 120.44, 
135.88, 143.08, 160.31, 165.24, 167.03 ppm. 
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Previous syntheses of Z-[p-(2-methyl-2-hydroxy- 
propyl)phenyl]propionic acid (1),lt2 a major human me- 
tabolite of ibuprofen (II), were considered unsuitable for 
preparation of large quantities of pure I which were re- 
quired for analytical studies. We report here a short, 
efficient synthesis of 2-[p-(2-methyl-2-hydroxypropyl)- 
phenyl] propionic acid, I, from ibuprofen, employing a novel 
1,6-eliminative cleavage of an epoxide which may have 
general application for remote functionalization of ap- 
propriate aromatic side chains. 
The key intermediate in this synthesis is the epoxide V 
which was obtained from I1 and subsequently converted 
to I by the method shown in Scheme I. Benzylic bro- 
mination of I1 with N-bromosuccinimide (NBS) provided 
a facile, selective entry into the isobutyl portion of the 
molecule. Although a benzylic proton was available in the 
propionic acid side chain, the a-COOH deactivated this 
position to a t t a ~ k . ~  Compound I11 was dehydrobromi- 
nated in DMF with LiBr to give the derivative IV in nearly 
quantitative yield. Initial attempts to effect this elimi- 
nation with other bases such as Li2C03, Et,N-i-Pr, DBN, 
and DBU gave only 25-7596 conversion to the olefin. 
Steric interactions of bromine and the gem-dimethyl group 
probably restrict formation of the trans configuration 
needed for the classic E2 elimination. The LiBr presum- 
ably coordinates with DMF to “lift” HBr from I11 in a cis 
f a ~ h i o n . ~  The olefin IV was treated with m-chloroper- 
benzoic acid (m-CPBA) to give the desired epoxide V. 
Attempts to hydrogenate V to give I directly using palla- 
dium or platinum catalysts in a variety of solvents were 
unsuccessful. During our investigation of methods to 
convert I11 to IV, we discovered an unusual reaction which 
became the key to the success of this synthesis. Treatment 
of I11 with potassium tert-butoxide in THF gave VII. The 
probable mechanism (Scheme 11) involves a 1,8elimination 
of HBr through the aromatic ring followed by rearoma- 
tization to the acrylic acid. Eliminations of the 1,6 variety 
involving a p-xylylene intermediate are proposed in one 
synthesis of [2.2]para~yclophanes.~ In our synthesis of 
I we observed that treatment of V with potassium tert-  
- V I  
(1) R. A. Johnson, C. M. Hall, W. C. Krueger, and H. C. Murray, Biorg. 
Chem., 2, 99 (1973). 
(2) R. J. Reischer and W. J. Wechter, private communication. 
(3) Bromination a to a‘carboxylate with N-bromosuccinimide has been 
reported, but much more vigorous conditions are required which involve 
in situ formation of an acyl halide. J. G. Gleason and D. N. Harpp, 
Tetrahedron Lett., 3431 (1970). 
(4) R. P. Holysz, J .  Am. Chem. SOC., 75, 4432 (1953). 
(5) (a) D. J. Cram and J. M. Cram, Acc. Chem. Res., 4, 204 (1971); (b) 
H. E. Winberg, F. S. Fawcett, W. E. Mochel, and C. W. Theobald, J .  Am. 
Chem. Soc., 82, 1428 (1960). 
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butoxide gave VI, presumably through the intermediate 
VIII. 
VI11 
The acrylic acid derivative VI was purified by recrys- 
tallization and then reduced quantitatively by catalytic 
hydrogenation with Pd/C to racemic I. The overall yield 
of I, from ibuprofen, by this method was 45% (70% from 
111). Since the hydrogenation of VI with an asymmetric 
rhodium catalyst has been reported to give predominately 
the R (or S) enantiomer of I,6 a stereoselective dimension 
of the synthetic pathway is available. 
Experimental Section 
Solvents were of reagent grade and were used without further 
purification. Reaction products were purified further when 
necessary by recrystallization. 
Thin-layer chromatography was performed on Merck 60Fm 
(0.25 mm) sheets and visualized under UV light. A Varian EM 
390 spectrometer was used for the NMR spectra (Me4Si as the 
internal reference). Mass spectra, melting points, and micro- 
analyses were performed by the Physical and Analytical chemistry 
Department a t  The Upjohn Company. 
2-[p-( l-Bromo-2-methylpropyl)phenyl]propionic Acid, 111. 
A solution of 240 g (1.16 mol) of ibuprofen (The Upjohn Com- 
pany), and 2.5 L of CC14 was refluxed for 10 min under N2, cooled 
to room temperature, and then treated with 190 g (1.06 mol) of 
(6) Belgian Patent 840,354, Oct 4, 1976, to The Boots Company, Ltd. 
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